Authors: Sievers, EL Larson, RA Stadtmauer, EA Estey, E Lowenberg, B Dombret, H Karanes, C Theobald, M Bennett, JM Sherman, ML Berger, MS Eten, CB Loken, MR van Dongen, JJM Bernstein, ID Appelbaum, FR

Citation: El. Sievers et al., Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse, J CL ONCOL, 19(13), 2001, pp. 3244-3254

Authors: Sherman, ML Moore, PA

Citation: Ml. Sherman et Pa. Moore, Chemical orientation of brown bullheads, Ameiurus nebulosus, under different flow conditions, J CHEM ECOL, 27(11), 2001, pp. 2301-2318

Authors: Bitetti, JM Sherman, ML

Citation: Jm. Bitetti et Ml. Sherman, Patient "Uncontrolled" Analgesia, ANESTHESIOL, 95(5), 2001, pp. 1306-1306

Authors: Oh, A Gulati, G Sherman, ML Golub, R Kutin, N

Citation: A. Oh et al., Bilateral eventration of the diaphragm with perforated gastric volvulus inan adolescent, J PED SURG, 35(12), 2000, pp. 1824-1826

Authors: Robertson, MJ Cameron, C Atkins, MB Gordon, MS Lotze, MT Sherman, ML Ritz, J

Citation: Mj. Robertson et al., Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer, CLIN CANC R, 5(1), 1999, pp. 9-16

Authors: Rook, AH Wood, GS Yoo, EK Elenitsas, R Kao, DMF Sherman, ML Witmer, WK Rockwell, KA Shane, RB Lessin, SR Vonderheid, EC

Citation: Ah. Rook et al., Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses, BLOOD, 94(3), 1999, pp. 902-908